second event in the somatic cell, homozygosity o~hemizygosity of a~ecessive mutation is obtained, leading to the formation of a tumor. As shown by the group of Cavenee (9, 10) and others, besides mutation or chromosome deletion, this second step may also involve abnormal chromosomal segregation events during mitosis. As both Wilm's tumor and retinoblastoma are embryonic tumors it is tempting to speculate that the genes involved play a part in the development of the target tissues during embryogenesis. Immune responsiveness toward all of the Amb V homologues was found to be significantly associated with the Dw2 subspecificity ofHLA-DR2 (4, 5, 7, 8) , even though these molecules show little, or no, antigenic crossreactivity (6) . The association with the Amb t V molecule is less striking than with Amb a V andAmb p V, where 95% or more responder subjects possess DR21Dw2. In the case of Amb a VI, 80% of responders possess HLA-DR5 (9) .
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We have used a refmed version of conventional allergen immunotherapy in a prospective genetic study of immune response to ragweed pollen allergens (10) which, to our knowledge, is the fIrst such study. Twelve matched pairs of DR2+ and DR2-patients were immunized sequentially with giant, western and short ragweed extracts containing known amounts of Amb t V,Amb p V andAmb a V, respectively. Serum was taken before and 12 times after increasing dosages (0.033-11 J.lg) of each Amb V. Eight of 12 DR2+ subjects made IgGAb responses to Amb tV (G.M. = 38 ng/ml), whereas 4/12 DR2-subjects made low levels of IgGAb (G.M. = 3.7 ng/ml); p<0.05 by t test Three of the four DR2+ nonresponders have atypical MLR responses toward Dw2 typing cells. Preliminary data show that 8 DR2+ subjects have positive immune responses to Amb p V and to Amb a V, with the exception of one DR2+lDw2-subject who failed to respond to Amb p V. However, all 8 DR2-subjects who have completed the Amb p V regimen, and all 5 DR2-subjects who have completed tJie Amb a V regimen, show no IgGAb. These data confirm the DR2IDw2 association with immune response to Amb t V and suggest that concordant response toward all three Amb V species is associated with the presence on the person's lymphocytes of the immune-associated (la) molecule, DR21Dw2. The data aIso provide evidence that a similar fila determinant" on all Amb V molecules is recognized by DR2IDw2 (or by an Ia specificity encoded by a gene in linkage disequilibrium with DR2/Dw2 in Caucasoid subjects).
Information concerning the structure of the Amb V Ia determinant can be inferred from the known amino acid sequences of Amb a V(3) and Amb t V(4), which show high degrees of homology at positions 17-26 and 31-35 (11). These two regions are probably linked by a disulphide bond and are also relatively hydrophobic. The latter property may stabilize the presence of the Ia determinant in the lipid bilayer of an appropriate antigen-presenting cell (APC), optimize a DR2-restricted antigen presentation to T cells and lead to an immune response. Further information regarding the structure of this putative Ia determinant comes from a comparison of the structures of the Amb V molecules with that of wheat germ agglutinin domains, which exhibit significant homology, especially in regard to the positions of their haIf-cystine residues (11, 12) . In regard to the Ia molecular structure, we are currently looking for differences in restriction (RFLP) maps of the DRfJ , DQfJ and DQa genes in DR2+ persons who have different immune response phenotypes to the Amb V allergens. We believe that these studies will lead to important new information concerning structurefunction relationships determining human immune responsiveness.
